Gene · 6536
Papers985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi criteria evaluation of schizophrenia drugs: DFT, ADMET, and molecular docking investigations. | Comput Biol Chem | 2026 | 42800397 | PubTator, text mining | PubMed |
| Novel SLC6A9 variants in an adult presenting with GlyT1 encephalopathy. | J Hum Genet | 2026 | 42728308 | PubTator, text mining | PubMed |
| Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives. | Pharmacol Ther | 2026 | 42668023 | PubTator, text mining | PubMed |
| Results from the first clinical trial of bitopertin for steroid-relapsed/refractory Diamond-Blackfan anemia. | Blood Red Cells Iron | 2026 | 42583025 | PubTator, text mining | PubMed |
| Emerging non-D2 receptor-based therapies for schizophrenia: a focus on muscarinic and glutamatergic pathways. | Front Psychiatry | 2026 | 42500322 | PubTator, text mining | PubMed |
| Pharmacokinetic/pharmacodynamic analysis to characterize the effect of long-term GlyT1 inhibitor iclepertin exposure on hemoglobin levels. | Front Pharmacol | 2026 | 42499503 | PubTator, text mining | PubMed |
| Clinicopathological and molecular characterization of HPV-associated cervical poorly cohesive carcinoma: a rare aggressive entity. | J Pathol Clin Res | 2026 | 42289532 | PubTator, text mining | PubMed |
| Accelerated Sampling of Protein Dynamics Using BioEmu-Augmented Molecular Simulation. | J Chem Inf Model | 2026 | 42268730 | PubTator, text mining | PubMed |
| Dendrobine inhibits the growth and invasion of human breast cancer cells by regulating the NF-κB signaling pathway via the SLC6A9 target. | Cytotechnology | 2026 | 42153166 | PubTator, text mining | PubMed |
| The Effect of Iclepertin on Hematological Parameters: An Overview of Nonclinical Studies and Clinical Trials in Healthy Volunteers and Patients with Cognitive Impairment Associated with Schizophrenia. | J Clin Pharmacol | 2026 | 42053463 | PubTator, text mining | PubMed |
| GlyT1 (SLC6A9) inhibition in neurological and psychiatric disorders. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41975102 | PubTator, text mining | PubMed |
| The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies. | Drugs R D | 2026 | 41903096 | PubTator, text mining | PubMed |
| SKA2 promotes gastric cancer progression by regulating glutathione metabolism. | iScience | 2026 | 41847110 | PubTator, text mining | PubMed |
| A Cross-Species Hydroquinone Model Replicates Smoking-Related Corneal Endothelial Oxidative Injury and Enables Therapeutic Screening of FGF10. | Invest Ophthalmol Vis Sci | 2026 | 41789845 | PubTator, text mining | PubMed |
| Health risk analysis of micro-and nanoplastic exposure via the microbiota-gut-brain axis. | Front Immunol | 2026 | 41789083 | PubTator, text mining | PubMed |
| Metabolic Mechanisms in Electroconvulsive Therapy for Schizophrenia: Role, Potential and Future Directions. | Int J Mol Sci | 2026 | 41751887 | PubTator, text mining | PubMed |
| The Tip-of-the-Tongue Phenomenon: Cognitive, Neural, and Neurochemical Perspectives. | Biomedicines | 2026 | 41751168 | PubTator, text mining | PubMed |
| RNA-Seq of Gingival Fibroblasts Grown on Collagen Membranes and Hyaluronic Acid. | J Funct Biomater | 2026 | 41745519 | PubTator, text mining | PubMed |
| Binder2030: a quantitative membrane proteome binding dataset enabling AI-driven drug discovery. | SLAS Discov | 2026 | 41740721 | PubTator, text mining | PubMed |
| Danggui Niantong granules in the treatment of rheumatoid arthritis - a mechanistic approach using ceRNA networks. | Front Pharmacol | 2026 | 41727546 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6536/papers